were produced as previous described;
Introduction
Autoimmune thrombocytopenic purpura (AITP) is a bleeding disorder caused by autoantibodies that opsonize platelets and enhance their destruction by FcR-mediated phagocytosis within the spleen. 1, 2 Although both acute and chronic forms can be distinguished, acute AITP primarily affects children and often occurs after a viral or bacterial infection. 1, 2 Furthermore, viralspecific antibodies with cross-reactivity against platelets have been identified in children with acute AITP 3, 4 and in patients with HIV-related AITP 4, 5 suggesting infections may play a role in AITP pathogenesis. On the other hand, in some patients with chronic AITP, infections are associated with an exacerbation of thrombocytopenia and this has also been demonstrated in a mouse model. 6 Alternatively, eradication of the gram negative bacterium H. pylori in patients with AITP increases platelet counts although this has not been observed in some studies. [7] [8] [9] [10] It is possible that, in susceptible individuals, infectious agents in the presence of anti-platelet antibodies affect plateletmonocyte interactions and alter platelet destruction.
Pathogens are first encountered by Toll-like receptors (TLR) on professional phagocytes. 11, 12 TLR are germline encoded proteins and bind a variety of infectious molecular structures and are critical for stimulating innate immune mechanisms. 11, 12 TLR are also expressed on many cell types including platelets [13] [14] [15] [16] [17] and platelet TLR4 expression, at least, appears responsible for mediating lipopolysaccharide (LPS)-induced thrombocytopenia in vivo. 15, 16 To determine how bacterial agents modulate platelet destruction, we used flow cytometry to investigate whether LPS affects opsonizedplatelet phagocytosis by mononuclear cells. The results demonstrate that LPS can synergize with IgG autoantibodies and significantly enhance platelet phagocytosis suggesting, at least, one mechanism of how bacterial products may enhance platelet destruction in vivo. were produced as previous described;
18 purity by HPLC analysis was >96%.
Platelets: Blood was obtained by venipuncture into trisodium citrate from healthy laboratory volunteers under an REB-approved protocol. PRP was prepared, platelets were counted and adjusted Statistical analysis: A one-way ANOVA was used to compare the means of W6/32 phagocytosis and a two-tailed paired t test for comparison between means was used for the patient sera..
Results and Discussion
Compared with non-opsonized platelets, when W6/32-opsonized platelets were incubated with THP-1 cells, a significant (p=0.0001) increase in intracellular platelet fluorescence occurred (0 value from Figure 1A compared with 0 value from Figure 1B ). In contrast, LPS-bound but non-opsonized platelets did not increases THP-1 intracellular platelet fluorescence ( Figure 1B) . If the LPS-bound platelets were, however, opsonized with W6/32, a significant (p<0.0001) and synergistic enhancement of opsonized platelet phagocytosis occurred ( Figure 1A ). The synergistic LPS/antibody enhancement of phagocytosis was Fc-specific because THP-1 phagocytosis was abrogated when the platelets were bound with W6/32 F(ab') 2 fragments ( Figure 1C ). This suggests that LPS bound to platelets in the presence of anti-platelet antibody significantly increases platelet phagocytosis by human mononuclear cells. The binding of bacterial products such as LPS to platelets has been demonstrated to mediate several physiological processes including platelet aggregation and platelet-monocyte interactions and may also play a role in atherogenesis. 19, 20 To our knowledge, however, this is the first demonstration of a synergistic effect between platelet-bound LPS and anti-platelet antibodies in enhancing platelet phagocytosis.
We then attempted to reproduce the W6/32 results with anti-platelet autoantibodies from the sera of patients with AITP. By flow cytometry, 4 of 8 sera were negative for IgG antiplatelet autoantibodies and 4 contained autoantibodies with titres ranging from 4 to 128. None of Figure   2A ), even when LPS was also bound to the platelets (solid bars, Figure 2A ). In contrast, however, 3 of the 4 autoantibody-positive sera (those with the higher titres: 64, 64 and 128) opsonized human platelets and enhanced their phagocytosis by the THP-1 cells (open bars, Figure 2B ). As with W6/32, when the autoantibody-opsonized platelets were also bound with LPS, their phagocytosis was significantly (p=0.0310, p=0.0481, p=0.0471) and synergistically enhanced (solid bars, Figure 2B ) when compared to only opsonized platelets (open bars, Figure   2B ). Thus, LPS in conjunction with IgG anti-platelet autoantibodies from patients with AITP can significantly enhance platelet phagocytosis.
These observations with LPS-bound platelets may be related to the recent reports demonstrating that platelets express toll-like receptors (TLR) and can bind LPS via TLR4. [13] [14] [15] [16] [17] The mechanism of how platelet-bound LPS together with autoantibody-opsonization synergizes to enhance platelet phagocytosis is unknown, but since the increase was Fc-dependent ( Figure   1C ), it may suggest that the interaction of TLR-and FcR-mediated signaling pathways could be responsible. For example, TLR signaling and phagocytosis are hallmarks of macrophagemediated innate immune responses to bacterial infections 21 and genes involved in Fc-dependent phagocytosis (e.g. Lyn and Syk) have been found to be up-regulated by TLRs. 22, 23 Furthermore, both FcR-and TLR-mediated phagocytosis appear coupled as several TLR family members are known to localize to phagosomes where they can recognize molecules specific to pathogens and mediate inflammatory signaling. 24, 25 Perhaps the combination of LPS and autoantibody presented by the platelets to the THP-1 cells utilize shared components that synergistically increase signaling events and maximally stimulate macrophage phagocytosis.
For personal use only. on November 16, 2017 . by guest www.bloodjournal.org From In summary, LPS together with IgG bound to platelets significantly enhances Fcmediated platelet phagocytosis by mononuclear phagocytes. These results suggest infectious agents in combination with anti-platelet antibodies could affect platelet destruction in vivo and may be at least one explanation of why thrombocytopenia worsens in some patients with AITP during infections and, alternatively, resolves in other patients with AITP who are treated with bacterial eradication therapy.
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